<?xml version="1.0" encoding="utf-8"?>
<Journal>
<Journal-Info>
<name>International Journal of Pharma and Bio Sciences</name>
<website>ijpbs.net</website>
<email>editorijpbs@rediffmail.com (or) editorofijpbs@yahoo.com (or) prasmol@rediffmail.com</email>
</Journal-Info>
<article>
<article-id pub-id-type='other'>10.22376/ijpbs.2019.10.1.p1-12</article-id>
<issue_number>Volume 3 Issue 1</issue_number>
<issue_period>2012 (January - March)</issue_period>
<title>Acute Toxicity Studies Of Fixed Dose Combination Of Ceftriaxone+Sulbactam+Ethylenediaminetetraacetic Acid In Swiss Albino Mice And Sprague Dawley Rats </title>
<abstract>The acute toxicity study of Ceftriaxone+Sulbactam+Ethylenediaminetetraacetic acid was investigated to offer a solution for the treatment of bacterial infection caused by beta lactam resistant pathogens. A single intra venous injection at the dose levels of 50 mg/Kg, 250 mg/Kg and 500 mg/Kg body weight were administered to  lessThan i greaterThan Swiss albino lessThan /i greaterThan  mice lessThan i greaterThan   lessThan /i greaterThan and  lessThan i greaterThan Sprague dawely lessThan /i greaterThan  rats (both male and female), where as control groups received normal saline. General behaviour , signs of toxicity, body weight, food and water consumption, and mortality were observed daily for 14 days. At the end of the study , hematological, biochemical, morphological and microscopic parameters were also determined. No toxicological meaningful difference, hazardous symptoms or death were observed in the acute toxicity test which indicates that a single i.v dose of Ceftraixone+sulbactam+EDTA combination at the dose levels of 50 mg/Kg, 250 mg/Kg and 500 mg/Kg body weight was not lethal in both mice and rats (male/female), and suggest a safe use in humans</abstract>
<authors>Manu Chaudhary And Krishnaraju V</authors>
<keywords>Acute toxicity, Mice, Rats,Ceftriaxone +Sulbactam+ EDTA</keywords>
<pages>110-122</pages>
</article>
</Journal>
